dr. stephen harrison's presentation from the nafld and nash primary care summit
Published 6 months ago • 593 plays • Length 15:11Download video MP4
Download video MP3
Similar videos
-
24:41
perspectives & discussions: nafld and nash screening, diagnosis, and emerging treatments
-
0:46
nash management in 2022 | prof. stephen harrison
-
8:00
from nafld to nash: is inflammation the culprit?
-
22:55
liver-directed drugs in the pipeline for fibrotic nash - s. harrison, md, facp, faasld col(ret.)
-
7:42
machine learning nafld and nash part 1
-
13:59
🔬 building a better future for patients with nafld and nash | fatty liver alliance
-
58:04
fatty liver disease webinar - july 2021
-
31:03
nonalcoholic fatty liver disease | jihane n. benhammou, md, phd | ucla digestive diseases
-
1:56
reversing nonalcoholic fatty liver disease (nafld)
-
25:12
current approaches to diagnosis and treatment of nafld
-
52:22
cardiovascular disease in nafld: identifying and managing cv risk
-
27:29
ask the experts presentation: faqs about fatty liver
-
58:18
nafld/nash present & future management options
-
43:18
ilc 2021 press conference 25 june - nafld / nash
-
49:24
nonalcoholic fatty liver disease
-
13:30
why endocrinologists do not screen for nafld as a complication of type-2 diabetes | kenneth cusi
-
16:32
fat and the liver in the african population | ponsiano ocama, mbchb, mmed, phd, fcp(ecsa)
-
4:49
heritability of nonalcoholic fatty liver disease
-
19:54
metabesity 2017: what do nash trials teach us?